Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
Top Cited Papers
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (10) , 1084-1091
- https://doi.org/10.1016/s0002-9149(02)02774-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ezetimibe co-administered with atorvastatin in 628 patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Ezetimlbe co-administered With slmvastatin in 668 patients With primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Rhabdomyolysis and HMG-CoA Reductase InhibitorsAnnals of Pharmacotherapy, 2001
- Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic functionBritish Journal of Pharmacology, 2001
- Pharmacodynamic interaction between fenofibrate and the cholesterol absorption inhibitor ezetimibeAtherosclerosis Supplements, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effect of ezetimibe on serum concentrations of lipid-soluble vitaminsAtherosclerosis Supplements, 2001
- Ezetimibe reduces low-density lipoprotein cholesterol: results of a phase III, randomized, double-blind, placebo-controlled trialAtherosclerosis Supplements, 2001
- Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663British Journal of Pharmacology, 2000
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993